Applied Filters
- Public Health
Journal Title
Topics
Publication Date
Author
- Foster, Angel M4
- Straus, Sharon E3
- Batal, Malek2
- Boozary, Andrew2
- Chan, Hing Man2
- Flood, Colleen M2
- Huey, Laura2
- Jones, Esyllt W2
- LaRoche, Kathryn J2
- McGrath, Patrick J2
- Mubareka, Samira2
- Stergiopoulos, Vicky2
- Taube-Schiff, Marlene2
- Ungar, Thomas2
- Vaughan, Adam D2
- Abou-Setta, Ahmed M1
- Alboim, Naomi1
- Amuasi, John1
- Andersen, Judith1
- Andrew, Leon1
- Andrew, Melissa1
- Ann Campbell, Mary1
- Anstruther, Se'era May1
- Archambault, Philippe1
- Archibald, Douglas1
Access Type
41 - 48of48
Save this search
Please login to be able to save your searches and receive alerts for new content matching your search criteria.
Filters
Search Name | Searched On |
---|---|
Subject Areas: Public Health (48) | 13 May 2024 |
You do not have any saved searches
- OPEN ACCESS
- Eric Kai-Chung Wong,
- Jennifer Watt,
- Hanyan Zou,
- Arthana Chandraraj,
- Alissa Wenyue Zhang,
- Jahnel Brookes,
- Ashley Verduyn,
- Anna Berall,
- Richard Norman,
- Katrina Lynn Piggott,
- Terumi Izukawa,
- Sharon E. Straus, and
- Barbara Arlena Liu
Atypical disease presentations are common in older adults with COVID-19. The objective of this study was to determine the prevalence of atypical and typical symptoms in older adults with COVID-19 through progressive pandemic waves and the association of these symptoms with in-hospital mortality. This retrospective cohort study included consecutive adults aged over 65 years with confirmed COVID-19 infection who were admitted to seven hospitals in Toronto, Canada, from 1 March 2020 to 30 June 2021. The median age for the 1786 patients was 78.0 years and 847 (47.5%) were female. Atypical symptoms (as defined by geriatric syndromes) occurred in 1187 patients (66.5%), but rarely occurred in the absence of other symptoms (n = 106; 6.2%). The most common atypical symptoms were anorexia (n = 598; 33.5%), weakness (n = 519; 23.9%), and delirium (n = 449; 25.1%). Dyspnea (adjusted odds ratio [aOR] 2.05; 95% confidence interval [CI] 1.62–2.62), tachycardia (aOR 1.87; 95% CI 1.14–3.04), and delirium (aOR 1.52; 95% CI 1.18–1.96) were independently associated with in-hospital mortality. In a cohort of older adults hospitalized with COVID-19 infection, atypical presentations frequently overlapped with typical symptoms. Further research should be directed at understanding the cause and clinical significance of atypical presentations in older adults. - OPEN ACCESSSince the initial outbreak in December 2019, the COVID-19 pandemic has resulted in more than four million deaths worldwide. Ecuador initially experienced one of the worst coronavirus outbreaks in the world. The pandemic quickly overwhelmed health care systems resulting in excess deaths of 37 000 from March to October, 2020. The public health measures taken to stop the spread of the virus had a devastating impact on the economy. There was a sharp contraction (7.8%) in Ecuador’s GDP in 2020. Furthermore, income poverty and inequality increased dramatically. The lasting effects of the pandemic will be harder to overcome. This article recounts and analyzes the COVID-19 pandemic in Ecuador, to draw lessons from this complex experience, and from the benefit of limited but important successes. We also aim to provide suggestions for best practices moving forward.
- OPEN ACCESS
- Michèle Hamers,
- Angie Elwin,
- Rosemary-Claire Collard,
- Chris R. Shepherd,
- Emma Coulthard,
- John Norrey,
- David Megson, and
- Neil D'Cruze
In Canada, there have been calls for increased research into and surveillance of wildlife trade and associated zoonotic disease risks. We provide the first comprehensive analysis of Canadian live wildlife imports over a 7-year period (2014–2020), based on data from federal government databases obtained via Access to Information requests. A total of 1 820 313 individual animals (including wild-caught and captive-bred animals but excluding fish, invertebrates, Columbiformes (pigeons), and Galliformes (game birds)), from 1028 documented import records, were imported into Canada during 2014–2020. Birds were the most imported taxonomic class (51%), followed by reptiles (28%), amphibians (19%), and mammals (2%). In total, 22 taxonomic orders from 79 countries were recorded as imported. Approximately half of the animals (49%) were imported for the exotic pet market. Based on existing literature and a review of the Canadian regulatory apparatus, we gesture to these importations' potential implications for zoonotic disease risk and discuss potential biosecurity challenges at the Canadian border. Finally, we identify data gaps that prevent an extensive assessment of the zoonotic disease risk of live wildlife imports. We recommend data collection for all wildlife importation and improved coordination between agencies to accurately assess zoonotic disease risk. - OPEN ACCESS
- Vanessa Gruben,
- Elaine Hyshka,
- Matthew Bonn,
- Chelsea Cox,
- Marilou Gagnon,
- Adrian Guta,
- Martha Jackman,
- Jason Mercredi,
- Akia Munga,
- Eugene Oscapella,
- Carol Strike, and
- Hakique Virani
The International Guidelines on Human Rights and Drug Policy recommend that states commit to adopting a balanced, integrated, and human rights-based approach to drug policy through a set of foundational human rights principles, obligations arising from human rights standards, and obligations arising from the human rights of particular groups. In respect of the Guidelines and standing obligations under UN Treaties, Canada must adopt stronger and more specific commitments for a human rights-based, people-centered, and public health approach. This approach must commit to the decriminalization of people who use drugs and include the decriminalization of possession, purchase, and cultivation for personal consumption. In this report, we will first turn to the legal background of Canada's drug laws. Next, we will provide an overview of ongoing law reform proposals from civil society groups, various levels of government, the House of Commons, and the Senate. We end with a three-staged approach to reform and a series of targeted recommendationscr. - OPEN ACCESS
- OPEN ACCESS
- Steve E. Hrudey,
- Heather N. Bischel,
- Jeff Charrois,
- Alex H. S. Chik,
- Bernadette Conant,
- Rob Delatolla,
- Sarah Dorner,
- Tyson E. Graber,
- Casey Hubert,
- Judy Isaac-Renton,
- Wendy Pons,
- Hannah Safford,
- Mark Servos, and
- Christopher Sikora
Wastewater surveillance for SARS-CoV-2 RNA is a relatively recent adaptation of long-standing wastewater surveillance for infectious and other harmful agents. Individuals infected with COVID-19 were found to shed SARS-CoV-2 in their faeces. Researchers around the world confirmed that SARS-CoV-2 RNA fragments could be detected and quantified in community wastewater. Canadian academic researchers, largely as volunteer initiatives, reported proof-of-concept by April 2020. National collaboration was initially facilitated by the Canadian Water Network.Many public health officials were initially skeptical about actionable information being provided by wastewater surveillance even though experience has shown that public health surveillance for a pandemic has no single, perfect approach. Rather, different approaches provide different insights, each with its own strengths and limitations. Public health science must triangulate among different forms of evidence to maximize understanding of what is happening or may be expected. Well-conceived, resourced, and implemented wastewater-based platforms can provide a cost-effective approach to support other conventional lines of evidence. Sustaining wastewater monitoring platforms for future surveillance of other disease targets and health states is a challenge. Canada can benefit from taking lessons learned from the COVID-19 pandemic to develop forward-looking interpretive frameworks and capacity to implement, adapt, and expand such public health surveillance capabilities. - OPEN ACCESS
- Linda Rabeneck,
- Chris McCabe,
- Mark Dobrow,
- Arlinda Ruco,
- Melissa Andrew,
- Sabrina Wong,
- Sharon Straus,
- Lawrence Paszat,
- Lisa Richardson,
- Chris Simpson, and
- Andrew Boozary
The purpose of this policy briefing is to examine our health care systems through the lens of the COVID-19 pandemic and identify how we can strengthen health care in Canada post-pandemic. The COVID-19 pandemic has provided compelling evidence that substantive changes to our health care systems are needed. Specifically, the pandemic has emphasized structural inequities on a broad scale within Canadian society. These include systemic racial and socioeconomic inequities that must be addressed broadly, including in the delivery of health care. We make recommendations about what we can do to emerge stronger from the pandemic. While these recommendations are not novel, how they are framed and contextualized differs because of the problems in our health care system that have been highlighted and exacerbated by the pandemic.The evidence is clear that socioeconomic circumstances, intergenerational trauma, adverse early life experiences, and educational opportunities are critical factors when it comes to health over the life course. Given the problems in the delivery of health care that the pandemic has revealed, we need a different approach. How health care was organized prior to the COVID-19 pandemic did not produce what people wanted and needed in terms of health care and outcomes. How do we emerge from COVID-19 with an effective, equitable, and resilient health care system for all Canadians?To address health inequities and emerge from the pandemic with strengthened health care in Canada, we must consider how Amartya Sen's capabilities framework on social well-being can be operationalized to achieve better health care and health outcomes. Specifically, we address the need to: strengthen primary care and improve access to primary care;utilize a community-embedded approach to care; andimplement better integration across the care continuum, including integration between primary care and public health.Coherent governance and leadership that are charged with realizing benefits through collaboration will maximize outcomes and promote sustainability. Only when we provide access to high-quality culturally competent care that is centered around the individual and their needs will we be able to make true headway in addressing these long-standing health inequities. - OPEN ACCESS
- James Conklin,
- Maryam Mohammadi Dehcheshmeh,
- Douglas Archibald,
- Jacobi Elliott,
- Amy Hsu,
- Anita Kothari,
- Paul Stolee, and
- Heidi Sveistrup
Long-term care (LTC) residents have an increased risk of social isolation and loneliness, and these risks were exacerbated by pandemic policies that restricted visitors. The designated care partner (DCP) program was introduced in some LTC homes to allow designated family members to safely enter the homes and provide support for residents. We undertook a developmental evaluation (DE) to support the development and implementation of the DCP program in three Ontario LTC homes during the COVID-19 pandemic. Data were collected from 65 staff and DCPs through seven iterations of a DE process. Analysis used directed and inductive coding and theming procedures to create a description of the DCP experience. Themes illustrated the barriers and facilitators to the DCP program and revealed a pervasive deficit of care due to inadequate funding, staff shortages, and an acrimonious relationship between staff and family members. Our project demonstrated a need for additional resources and stronger partnerships between staff and family caregivers.